Brandywine Managers’s Moderna MRNA Stock Holding History

Brandywine Managers’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$666K	Hold	9,510	–	–	0.33%	32
2026 Q1	$483K	Hold	9,510	–	–	0.28%	29
2025 Q4	$280K	Hold	9,510	–	–	0.14%	37
2025 Q3	$246K	Hold	9,510	–	–	0.24%	33
2025 Q2	$262K	Hold	9,510	–	–	0.26%	29
2025 Q1	$270K	Hold	9,510	–	–	0.32%	28
2024 Q4	$395K	Hold	9,510	–	–	0.42%	26
2024 Q3	$636K	Hold	9,510	–	–	0.68%	21
2024 Q2	$1.13M	Hold	9,510	–	–	1.19%	13
2024 Q1	$1.01M	Hold	9,510	–	–	1%	14
2023 Q4	$946K	Hold	9,510	–	–	1.04%	13
2023 Q3	$982K	Hold	9,510	–	–	1.66%	10
2023 Q2	$1.16M	Hold	9,510	–	–	0.76%	15
2023 Q1	$1.46M	Hold	9,510	–	–	1.04%	12
2022 Q4	$1.71M	Hold	9,510	–	–	5.97%	3
2022 Q3	$1.13M	Hold	9,510	–	–	3.7%	5
2022 Q2	$1.36M	Hold	9,510	–	–	3.33%	4
2022 Q1	$1.64M	Hold	9,510	–	–	2.83%	5
2021 Q4	$2.42M	Hold	9,510	–	–	2.74%	6
2021 Q3	$3.66M	Hold	9,510	–	–	3.82%	5
2021 Q2	$2.23M	Hold	9,510	–	–	2.55%	7
2021 Q1	$1.25M	Buy	9,510 +414	+5%	+$60K	1.65%	12
2020 Q4	$950K	Hold	9,096	–	–	1.31%	15
2020 Q3	$644K	Hold	9,096	–	–	1.22%	16
2020 Q2	$584K	Sell	9,096 -1,000	-10%	-$54.8K	2.4%	13
2020 Q1	$302K	Hold	10,096	–	–	0.11%	21
2019 Q4	$197K	Sell	10,096 -2,500	-20%	-$44.3K	0.06%	47
2019 Q3	$201K	Hold	12,596	–	–	0.07%	46
2019 Q2	$184K	Buy	12,596 +96	+0.8%	+$2.06K	0.07%	47
2019 Q1	$254K	Sell	12,500 -3,600	-22%	-$66.8K	0.1%	45
2018 Q4	$246K	Buy	+16,100	New	+$265K	0.12%	38

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Brandywine Managers's MRNA Position: Q2 2026 in Review

Brandywine Managers held its Moderna (MRNA) position steady in Q2 2026 at 9,510 shares worth $666K. The position accounts for 0.33% of the portfolio, ranked #32.

Brandywine Managers first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.66M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Brandywine Managers held 9,510 shares of Moderna worth $666K as of Q2 2026.
Brandywine Managers left its Moderna share count unchanged in Q2 2026.
Moderna made up 0.33% of Brandywine Managers's portfolio in Q2 2026, its #32 holding.
Brandywine Managers first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
Brandywine Managers's Moderna position peaked at $3.66M in Q3 2021.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Brandywine Managers's 13F filing for Q2 2026, filed 14 Aug 2026.